Save Studies Locally

We can save your selected studies locally in your browser to enhance your experience. This data stays on your device and is not shared with us or third parties. You can clear this data at any time.

By allowing this, you consent to storing study selections locally on your device. Privacy Policy

Evaluation of 64Cu-ATSM PET/CT in Predicting Neo Adjuvant Treatment Response in Locally Advanced Rectum Cancer

Description:

This phase II trial is assessing how 64Cu-ATSM (64Cu-copper(II) diacetylbis(N4-methylthiosemicarbazone)) PET/CT scan could predict neo adjuvant treatment response in rectum cancer locally advanced

Sponsor:

Institut Cancerologie de l'Ouest

Contacts:

Mathilde COLOMBIE, MD

mathilde.colombie@ico.unicancer.fr

+33240679900 ext 9501

Nadia ALLAM, PhD

nadia.allam@ico.unicancer.fr

+33240679826

XCancer

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468